Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
- 31 January 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 172 (1), 123-131
- https://doi.org/10.2353/ajpath.2008.070627
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service (P30AG10133)
- European Molecular Biology Organization (P30AG10133)
- Alzheimer's Research Trust (P30AG10133)
- Medical Research Council (P30AG10133)
This publication has 38 references indexed in Scilit:
- A Century of Alzheimer's DiseaseScience, 2006
- Sequential phosphorylation of tau protein by cAMP‐dependent protein kinase and SAPK4/p38δ or JNK2 in the presence of heparin generates the AT100 epitopeJournal of Neurochemistry, 2006
- Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivoJournal of Neurochemistry, 2006
- Cell-Cycle Markers in a Transgenic Mouse Model of Human Tauopathy: Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1The American Journal of Pathology, 2006
- Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau miceNeurobiology of Disease, 2004
- Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular Aβ and Synaptic DysfunctionNeuron, 2003
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycansNature, 1996
- Characterization of mAb AP422, a novel phosphorylation‐dependent monoclonal antibody against tau proteinFEBS Letters, 1996
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995